Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis

Immune thrombocytopenia (ITP) may occur in isolation (primary) or in association with a predisposing condition (secondary ITP [sITP]). Eltrombopag is a well-studied treatment for primary ITP, but evidence is scarce for sITP. We evaluated real-world use of eltrombopag for sITP using electronic health...

Descripción completa

Detalles Bibliográficos
Autores principales: Patwardhan, Pallavi, Landsteiner, Adrienne, Lal, Lincy S., Geevarghese, Lincy, Le, Lisa, Nandal, Savita, Cuker, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720735/
https://www.ncbi.nlm.nih.gov/pubmed/34505942
http://dx.doi.org/10.1007/s00277-021-04637-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720735/
https://www.ncbi.nlm.nih.gov/pubmed/34505942
http://dx.doi.org/10.1007/s00277-021-04637-2

Ejemplares similares